Camrelizumab monotherapy leading to partial remission for relapsed upper tract urothelial carcinoma after radical nephroureterectomy: a case report

Upper tract urothelial carcinoma (UTUC) is a rare malignant disease, and while locally advanced non-metastatic UTUC can be cured by radical nephroureterectomy (RNU), this procedure leaves patients at high risk of relapse and death from cancer. Though the FDA has currently approved five agents for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Kangxin, Wang, Zhenghui, Yu, Shicheng, Zheng, Jintong, Li, Gonghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100841/
https://www.ncbi.nlm.nih.gov/pubmed/33968671
http://dx.doi.org/10.21037/tau-21-268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100841/
https://www.ncbi.nlm.nih.gov/pubmed/33968671
http://dx.doi.org/10.21037/tau-21-268

Ejemplares similares